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Intermittent pneumatic compression: Physiologic
and clinical basis to improve management of
venous leg ulcers
Anthony J. Comerota, MD, Toledo, Ohio; and Ann Arbor, Mich
Venous leg ulcers (VLUs) are a significant health problem that afflicts 1% of the population at some point during their
lifetime. Intermittent pneumatic compression (IPC) is widely used to prevent deep venous thrombosis. However, IPC
seems to have application to a broader base of circulatory diseases. The intermittent nature of pulsatile external
compression produces beneficial physiologic changes, which include hematologic, hemodynamic, and endothelial effects,
which should promote healing of VLUs. Clinical studies of the management of VLUs show that IPC increases overall
healing and accelerates the rate of healing, leading to current guideline recommendations for care of patients with VLUs.
Proper prescription of IPC to improve the management of patients with VLUs requires further definition. It seems that
application of IPC in combination with sustained graduated compression improves outcome in patients with the most
advanced venous disease. ( J Vasc Surg 2011;53:1121-9.)
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lIntermittent pneumatic compression (IPC) is an effec-
tive treatment for a variety of circulatory disorders. Its use
for venous thromboembolism prophylaxis and treatment of
lymphedema are well established.1 IPC also improves walk-
ing distance in patients with intermittent claudication and
is effective in patients with critical limb ischemia (CLI).
However, the focus of this discussion will be the utility of
IPC for the management of advanced chronic venous dis-
ease, specifically venous ulceration.1
Venous leg ulcers (VLUs) impose a major healthcare
burden on the patient and the healthcare system. The direct
and indirect costs of chronic venous disease (CVD) have
been estimated at one billion U.S. dollars per annum.2 This
review addresses the etiology of VLUs, the importance of
compression in their management, the hemodynamic and
hematologic effects of IPC, and the clinical outcomes ob-
served when IPC is used to treat VLUs.
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VLUs occur in approximately 1% to 2% of the popula-
ion.3-5 The underlying pathophysiology is ambulatory ve-
ous hypertension resulting from valvular incompetence,
bstruction of the vein lumen, or both. Valve incompe-
ence can result from a primary defect in the vein wall or be
econdary to the inflammatory and fibrotic sequelae of
enous thrombosis. Acute deep venous thrombosis (DVT)
an obstruct the vein, subsequently causing valvular dys-
unction in nonthrombosed distal veins, and impair calf
uscle pump function. Prolonged immobility and obesity
lso result in calf muscle pump dysfunction, venous pool-
ng, and chronic edema. Valvular dysfunction can occur
hen individuals with a genetic predisposition for venous
nsufficiency are exposed to risk factors, such as pregnancy
r periods of prolonged standing. Regardless of its etiol-
gy, however, the ensuing venous stasis, which is charac-
erized by the formation of edema and a rise in tissue
ressure, plays a major role in the development of venous
lcers.
ATHOPHYSIOLOGY OF VENOUS LEG
LCERS
Two important hemodynamic pumps (the calf and foot
umps) propel blood proximately from their respective
enous reservoirs. Contraction of calf muscles activates the
alf pump, which drains blood from both calf and foot,
hereas pressure on the plantar arch (during ambulation)
mpties blood from the plantar venous plexus through the
ateral plantar vein. Ineffective leg pumps, together with
ncompetent venous valves, lead to elevated tissue pressure
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April 20111122 Comerotaand edema. Individuals with associated venous obstruction
have the highest ambulatory venous pressure. Venous hy-
pertension increases capillary permeability, and the result-
ing blood and fluid leakage into tissue causes edema, pig-
mentation, and tissue fibrosis.6,7
The mechanism by which prolonged venous hyperten-
sion causes venous ulcers is the subject of several theories.
Browse and Burnand8 suggested that venous hypertension
resulted in a distended capillary bed and enlarged endothe-
lial pores, allowing fibrinogen to escape into the interstitial
fluid. They proposed a “fibrin-cuff” hypothesis based on
their observation that pericapillary fibrin formed a “cuff”
around an enlarged dermal capillary bed, with the fibrin
acting as a barrier to tissue oxygenation, causing hypoxia-
induced ulceration.
The “fibrin-cuff” hypothesis has been superseded by
more recent theories, indicating that chronic inflammation
plays a crucial role in the progression of CVD.9 Although
the precise events that initiate this inflammatory response
are not known, it seems to involve leukocyte-endothelial
interactions triggered by abnormal venous return and ve-
nous hypertension.9 Prolonged pooling of venous blood
distends the vein and distorts venous valves, allowing leak-
age through the valves. This pooling creates a region of low
flow and zero-shear stress. The resultant venous hyperten-
sion, leukocyte activation, and adhesion to and emigration
through the venous endothelium trigger inflammatory re-
actions, further increasing capillary permeability.10,11
Regardless of its etiology, however, prolonged venous
hypertension initiates the progression of a series of patho-
logic events, causing effects at a cellular level and resulting
in the clinical signs and symptoms of CVD, which can
ultimately result in skin breakdown and ulceration.
SUSTAINED COMPRESSION: THE
CORNERSTONE OF VENOUS LEG ULCER
TREATMENT
Sustained compression is the cornerstone of VLU ther-
apy, the goal of which is to promote ulcer healing and
prevent recurrence. However, the healing of venous ulcers,
especially those that are large and longstanding, may not
occur, even after many months of treatment.10 Several
randomized studies have shown that only 37% to 55% of
ulcers heal completely after 12 weeks of compression ther-
apy.11-13 The VenUS I trial, which randomized two types
of compression bandages for treating VLUs in 387 pa-
tients, found that 37% healed with short-stretch bandages
at 12 weeks vs 46% treated with four-component, multi-
layer bandages.11 The respective healing rates at 24 weeks
were 68% and 55% (P .05). Short-stretch bandages retain
some elasticity, whereas four-component, multilayer ban-
dages are essentially inelastic and apply persistent pressure
to the limb, more when the patient is upright, less when
supine. In a trial of 200 patients with VLUs randomized to
treatment with either four-component bandages or usual
care (control group), O’Brien et al12 reported that the
healing rate at 3 months was 54% with four-component
bandages vs 34% with usual care (P .001). However, only gpatients in the “usual care” group received compression,
hich seems to be a common scenario in many medical
ommunities. Lyon et al13 treated 165 patients with
hronic venous ulcers with a hydrocolloid dressing and
pplication of an Unna boot. Healing was achieved in 55%
y 12 weeks. A subsequent analysis of the data by Phillips et
l14 suggested that ulcers that are large, longstanding, and
low to heal after 3 weeks of optimal therapy are unlikely to
esolve rapidly andmay benefit from alternative treatments.
Tinkler et al5 found that 34% of ulcers treated with
hree-component bandages and 32% of those treated with
our-component bandages healed by 12 weeks. Because the
egree of compression was likely similar with the two
andaging techniques, similar results would be anticipated.
HYSIOLOGIC EFFECTS OF INTERMITTENT
NEUMATIC COMPRESSION
Table I summarizes the hemodynamic and hemato-
ogic effects of IPC.
Hemodynamic effects. Sustained compression ap-
lied by multilayer bandages reduces venous hypertension;
owever, it only passively promotes venous return com-
ared to IPC.9 IPC actively compresses the leg, mimicking
he action of the leg muscle pumps. The device, which may
ave one or more chambers, consists of a pneumatic pump
hat inflates air into garments wrapped around the foot,
alf, thigh, or combinations thereof. Devices with multiple
hambers can provide sequential compression in an ascending
attern up the limb. Pumps vary in their timing cycle and
mount of pressure produced, ranging from low-pressure,
low-inflation to high-pressure, and rapid-inflation devices.
IPC reduces venous stasis and increases flow velocity in
he deep veins, resulting in favorable hemodynamic
hanges such as decreased venous pressure and interstitial
dema.1,7 IPC produces increases in venous volume flow
nd increased venous flow velocity, causing increased shear
tress.15 Research studies in animals have shown that these
echanical forces result in endothelial cell responses that
ontribute to the profibrinolytic, vasodilatory, and anti-
hrombotic effects of IPC.1
Malone et al16 compared the effects of high-pressure,
apid-inflation IPC vs low-pressure, slow-inflation IPC on
1 healthy subjects and 11 patients with postthrombotic
enous disease. Although both systems increased the veloc-
ty in femoral and popliteal veins in all study participants,
he high-pressure, rapid-inflation devices produced the
ighest peak velocities (P  .05). All venous velocities,
oth baseline and stimulated by IPC, were significantly
ttenuated in postthrombotic patients.
Hematologic effects. The mechanisms by which IPC
nduces hematologic alterations has been studied and clar-
fied. Changes in blood coagulation are attributed to in-
reased shear stress on the vein wall. This is consistent with
he results of studies in cell culture models showing that
ncreasing shear stress on endothelial cells increases produc-
ion of prostacyclin, endothelial-derived relaxing factor,
latelet-derived growth factor, and tissue-type plasmino-
en activator.17-20
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Volume 53, Number 4 Comerota 1123IPC alters fibrinolytic activity and seems to affect two of
the three limbs of Virchow’s triad: stasis and hypercoagu-
lability. Endogenous fibrinolysis results from the conver-
sion of plasminogen to plasmin through the action of one
of two activators, tissue-type plasminogen activator (tPA)
and/or urokinase-type plasminogen activator (uPA). Lytic
activity is neutralized when plasminogen activator is bound
by circulating plasminogen activator inhibitor-1 (PAI-1)
and when plasmin is bound by -2-antiplasmin.
Comerota et al21 proposed the mechanism by which
Table I. Physiologic effects of IPC
Category Physiologic effect1,10,18
Potential direct
and indirect
benefits1,10,24-25,28
Hemodynamic/
hematologic
2Venous stasis
1 Flow velocity in deep
veins
1 Fibrinolysis
2Venous pressure
1Interstitial edema
1Thrombogenicity
1Intravascular
coagulation
1Blood volume flow
1Endothelial shear stress
2A-V pressure gradient
1Venous emptying
2Stasis
2Edema
1Arterial inflow
1Shear stress/on
endothelial strain
cells
1Fibrinolysis
1Vasodilation
2Thrombosis
Category Physiologic effect24-25
Potential direct
and indirect
benefits20-22.24-25
Hemodynamic/
hematologic
(cont’d)
1Prostacyclin
production
2Endothelial-
derived relaxing
factor
2Platelet-derived
growth factor
Fibrinolytic/
hematologic
1Fibrinolytic
activity
2tPA antigen
1tPA activity
2PAI-1 antigen
2PAI-1 activity
1Endogenous
fibrinolytic activity
2FVIIa levels
1TFPI levels
1Thrombosis
2Intravascular
coagulation
2Hypercoagulability
Category Physiologic effect26-28
Potential direct and
indirect benefits26,28
Tissue oxygen
tension
1TcPO2 levels
2Interstitial fluid
volume
2Venous stasis
1Oxygen diffusion
barrier
2Leg edema
1Skin temperature
Edema 2Arteriovenous
shunting
2Edema
1Capillary
perfusion
1Skin nutrition
A-V, Arterio-venous; FVIIa, factor; IPC, intermittent pneumatic compres-
sion; PAI-1, plasminogen activator inhibitor-1; TcPO2, transcutaneous ox-
ygen tension; TFPI, tissue factor pathway inhibitor; tPA, tissue plasminogen
activator; VIIa.IPC increases fibrinolytic activity based on the results of a iontrolled study evaluating normal subjects and patients
ith post-thrombotic CVD. Fibrinolytic activity was as-
essed using a calibrated fibrin-plate assay, which assesses
otal fibrinolytic activity in the blood. Also studied were
PA and PAI-1 antigen and activity, plasmin generation,
nd von Willebrand factor (vWF) as a gauge of endothelial
timulation. Interestingly, but not surprisingly, baseline
ndogenous fibrinolytic activity was significantly attenu-
ted in postthrombotic patients (P  .01). IPC increased
ndogenous fibrinolytic activity in all patients. However,
he increase of fibrinolytic activity of postthrombotic pa-
ients was attenuated, essentially reaching baseline levels
bserved in healthy patients. Interestingly, IPC reduced
PA antigen, whereas tPA activity significantly increased
PA activity. IPC reduced PAI-1 antigen and activity; how-
ver, there was no change in vWF. These observations
uggest that the increase in fibrinolytic activity is due to a
eduction in PAI-1, most likely resulting from increased
learance. Unlike cell culture studies, there was no increase
n the release of tPA from endothelial cells.
Extending the findings of Comerota et al,21 Chouhan
t al22 examined the onset of intravascular coagulation
hrough the tissue factor (TF) pathway. IPC reduced factor
IIa (FVIIa) levels for both healthy patients and post-
hrombotic patients compared with their baseline values
P .001). There was a greater (P .05) decrease in FVIIa
evels in healthy patients (18% to 24% of baseline values)
han in patients with postthrombotic venous disease (40%
o 43% of baseline values). Likewise, there was a greater
ncrease in tissue factor pathway inhibitor (TFPI) levels in
ealthy patients than in post-thrombotic patients (P 
001). An inverse relationship was found between FVIIa
nd TFPI levels, demonstrating inhibition of the TF-
ependent pathway.
These findings suggest that IPC stimulates the release
f TFPI from the endothelial TFPI pool and indicate that
eduction of intravascular coagulation through inhibition
f the TF pathway may be a key mechanism for the anti-
hrombotic effect of IPC.
Effects on oxygen tension. When edema occurs and
ncreases extravascular pressure, perfusion pressure de-
reases, reducing dermal oxygen tension. Kolari et al23
ostulated that IPC would increase transcutaneous oxygen
ension (TcPO2) and contribute to ulcer healing by de-
reasing interstitial fluid volume and venous stasis. They
ompared the effect of IPC in 10 patients with post-
hrombotic leg ulcers and 9 healthy patients and found that
cPO2 increased in 9 of 10 patients. Baseline TcPO2 was
reater in healthy patients (P  .01) than in patients with
eg ulcers, both before and after IPC. The change in TcPO2
f patients directly correlated with a reduction of leg edema
nd inversely correlated with skin temperature (P .002).3
hese results support the hypothesis that an oxygen diffu-
ion barrier is present in the tissue surrounding venous
lcers and suggest that IPC increases tissue perfusion and
ecreases interstitial fluid volume in the leg, resulting in
mproved oxygen diffusion.
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April 20111124 ComerotaA subsequent study by Nemeth et al24 in patients with
venous ulcers and pitting edema failed to show an increase
of TcPO2 with IPC. Nemeth et al
24 and Kolari et al23 used
different devices, with markedly different inflation times
and cycles. The cycle times in the Kolari et al23 study were
30 seconds (12-second inflation, 18-second deflation)
compared to 120 seconds (90-second inflation, 30-second
deflation) in the Nemeth et al24 study. Because normal
venous refill times are 25 seconds or less, it is understand-
able that a 30-second cycle time (two compressions/min-
ute) would be superior to a 120-second cycle time (one
compression every 2 minutes). The shorter cycle time max-
imizes endothelial shear stress and emptying of venous
blood from the leg.
Effects on edema. A number of studies have shown
that IPC reduced edema in patients with CVD and VLUs.
Malanin et al25 investigated the hemodynamic and volu-
metric effects of IPC in patients with VLUs and recorded
tibial artery Doppler scan waveforms and skin perfusion
with laser Doppler flux. IPC produced a significant reduc-
tion in leg volume in patients with VLUs compared to
healthy patients (P  .016). The authors suggested that
reduction of edema leads to a redistribution and increase of
skin blood flow favoring superficial capillary perfusion.
Effects of intermittent pneumatic compression on
arterial perfusion. Emptying of the venous blood from
larger veins and venules of the leg increases the arterial-
venous pressure gradient. By taking advantage of this prin-
ciple, IPC was studied as a method to improve arterial
blood flow.26-40 Early investigation using massage pumps
on the lower extremity of individuals in the upright posi-
tion demonstrated reduced venous pressures.26 The pres-
sure in arteries of the dependent lower extremity will in-
crease by an amount corresponding to their distance below
the heart. An arterial-venous pressure differential of 30 to
40 mmHg or more can be produced with IPC resulting in
an increased perfusion pressure, which naturally leads to an
increase of total blood flow to the part of the extremity
being compressed. As early as 1957, Allwood41 demon-
strated that intermittent leg compression in the normal
individual could increase blood flow by 60% and by 30% in
patients with arterial occlusive disease.
Henry and Winsor26 also demonstrated increased foot
perfusion when they recorded rapid clearance of I-131
from tissues of the foot because of calf compression. Ve-
nous pressure and tissue pressure were reduced and oxygen
tension in blood from the veins of the dorsum of the foot
was increased. The authors speculated that if the foot and
calf were compressed, lower venous pressures and higher
arterial-venous pressure gradients would be achieved than
with calf compression alone, with a corresponding im-
provement in foot perfusion.
Eze et al42 studied the influence of combined foot and
calf compression on foot skin perfusion and popliteal artery
blood flow in normal volunteers and claudicants with su-
perficial femoral artery occlusion. High-pressure (120 mm
Hg), rapid-inflation (0.3 seconds) compression was used at
two cycles/minute. Skin blood flow to the great toe in- oreased by 328% in control patients and 188% in claudi-
ants, whereas popliteal artery blood flow increased by
73% and 50% in controls and claudicants, respectively.
hey found that foot skin perfusion was optimized with
oot compression alone, whereas optimal popliteal artery
lood flow was observed with combined foot and calf
ompression. These authors went on to characterize the
ource of improved foot skin perfusion that potentially
ould be from increased arterial inflow or venous reflux
esulting from proximal compression. They found that 86%
o 93% of the increased foot skin perfusion was due to
mproved arterial flow and 7% to 14% due to venous reflux.
reater venous reflux was observed in individuals who
xercised (perhaps reflecting peripheral vasodilation),
hereas lesser reflux was observed in sedentary patients.
Investigators have used IPC to treat patients with in-
ermittent claudication and CLI.31-40 Randomized trials of
PC in patients with intermittent claudication have demon-
trated improved walking distances associated with an in-
rease in their ankle-brachial index.
The degree of improved arterial perfusion is reduced in
atients with occlusive disease. However, substantial in-
reases in blood flow and foot skin perfusion have been
ocumented in patients with CLI. The number of patients
reated with IPC for CLI is limited and the studies are not
ell controlled. However, investigators have reported bet-
er than anticipated outcomes in patients with end-stage
LI who had no options for revascularization.34,39,40
Because patients with venous leg ulcers have reduced
utritional blood flow to the skin and reduced TcPO2
23,
mproved arterial perfusion to the limb and improved skin
erfusion represent additional and important mechanisms
y which patients with venous ulcers benefit from IPC.
SE OF INTERMITTENT PNEUMATIC
OMPRESSION IN PATIENTS WITH VENOUS
EG ULCERS
Ever since McCulloch43 suggested the use of IPC for
he treatment of venous ulcers in 1981, evidence has been
ccumulating supporting IPC as an adjunctive method to
peed the healing of venous ulcers (Table II). This review
nly includes studies that report 10 or more patients. In
981, Hazarika and Wright44 reported a prospective, con-
rolled trial evaluating the effects of a single-chamber IPC
evice on ulcer healing in 21 patients with VLUs. Nine
atients received IPC treatment and 12 served as controls.
PC patients were allowed to select their pressure settings
30-80 mmHg) and were instructed how to use the device
t home for 2 to 3 hours daily. All but 1 of the IPC patients
xhibited subjective and/or objective healing of their ulcers
fter 10 to 40 weeks of IPC treatment, whereas 11 of the 12
ontrol patients showed no change or worsening of their
ondition. Importantly, it was the patients with the most
evere and longstanding ulcers that showed improved ulcer
ealing with IPC.
In a prospective, randomized, controlled study, Mc-
ulloch et al45 examined the effects of single-chamber IPC
n rates of venous ulcer healing. All 22 patients enrolled in
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 4 Comerota 1125Table II. Use of IPC in the treatment of VLUs: study summary
Investigator Study design
No.
patients IPC protocol Duration Results Comments
Hazarika and Wright44 Prospective,
controlled
trial. All
patients
previously
treated with
compression
bandages and
topical agents.
Outpatient
study.
21 2-3 h/d IPC with a
single-chamber
sleeve. Inflation
to 30-80 mm
Hg  120 s,
followed by 135 s
deflation.
44 wks 8/9 (89%) test
subjects
improved;
11/12 (92%)
control
subjects no
change or
worsening.
Case series; no ITT
analysis;
inconsistent
compliance.
McCulloch et al45 Randomized;
controlled; 12
IPC  Unna
boot vs 10
Unna boot
alone.
Outpatient
study.
22 Single-chamber
IPC 1 h 2/wk
at 50 mm Hg 
90 s, followed by
30 s deflation.
6 mo Ulcer healing:
12/12 – IPC
8/10 – control
Healing rate:
0.15 cm2/d –
IPC
0.06 cm2 –
control (P 
.05).
Control patients
were older.
Unclear whether
initial ulcer size
was comparable
between groups.
Smith et al46 Randomized; 21
patients to
wound care,
stockings plus
IPC; 23
patients to
wound care,
stockings;
controlled;
‘intention to
treat’ analysis.
Ulcers present
12 wks.
Outpatient
setting.
45 All subjects received
30-40 mm Hg
graduated
compression
stockings and
routine wound
care. Sequential
IPC applied up
to 4 h/d:
Ankle – 50 mm Hg
Calf – 45 mm Hg
Thigh – 40 mm Hg
3 mo Ulcer healing:
10/21 – IPC
1/23 – control
P  0
Healing rate
(surface
area/wk):
19.8% – IPC
2.1% – control
(P  .046).
Well-controlled
trial. IPC applied
over
compression
stocking. IPC
cycle time not
specified.
Mulder et al47 Open-label
cohort study;
historical
controls;
chronic (1 y)
venous ulcers.
All patients
had no
improvement
after 42 d of
Unna’s boot.
10 Sequential IPC 
1 h in the AM
and 2 h in the
PM:
Ankle – 50 mm Hg
Calf – 45 mm Hg
Thigh – 40 mm Hg
1 y All patients
improved (P
 .01); 1
patient
healed by 4
mo. All
patients
healed by
1 y.
Small sample size;
IPC cycle times
not specified.
Schuler et al48 Randomized
comparison.
IPC  30 mm
Hg elastic
stocking vs
Unna’s boot.
Outpatient
setting.
54 IPC patients given
30 mm Hg
elastic stocking.
Graduated
compression
IPC  1 h in the
AM and 2 h in
the PM:
Foot – 10 mm Hg
Calf to ankle – 50,
45, 40 mm Hg at
2.5 s intervals.
12 s
compression;
60 s deflation.
6 mo Ulcer healing:
20/28 – IPC
 stocking.
15/25 –
Unna’s
boot.
Healing rates
similar and
correlated
with
pretreatment
ulcer size.
Less pain (P
 .03) and
exudate (P
 .05) in
Effects of IPC not
evaluated in a
controlled
setting. The 30
mm Hg stocking
was probably less
effective than the
Unna’s boot for
leg ulcer
treatment.IPC group.
m
v
t
(
a
h
w
v
u
w
s
p
a
JOURNAL OF VASCULAR SURGERY
April 20111126 Comerotathis trial received local wound care and application of an
Unna boot. Twelve patients were randomized to IPC treat-
ment twice weekly for 1 hour per session. Follow-up visits
were conducted twice weekly for 6 months or until the
ulcers healed. Results showed that ulcer healing occurred in
all 12 of the patients who received IPC and in 8 of 10
control patients. Ulcer healing rate was more rapid in
patients receiving IPC (0.15 cm2 per day) compared to
patients in the control group (0.08 cm2 per day; P  .05).
It is interesting that benefit from IPC (speed of healing)
was observed in light of what most would consider minimal
use of IPC. Because edema occurs on a daily basis and is
worse in the later hours of the day, longer durations of IPC
delivered on a daily basis would mitigate the effects of
venous hypertension, increasing the likelihood of salutary
Table II. Continued
Investigator Study design
No.
patients IPC
Alpagut and Dayioglu49 Prospective, non-
randomized
trial of 159
patients with
post-
thrombotic
venous ulcers
given routine
care of: leg
elevation,
compression
with elastic
stockings, oral
and IV
anticoagulants,
and systemic
antibiotics. 76
received IPC
in addition to
compression
stockings.
Inpatient and
outpatient
setting.
235 1 h/d o
cham
70 m
press
cycle
inflat
susta
comp
20 s
Nikolovska et al50 Randomized trial
(1:1) in
patients with
venous ulcers.
Rapid
inflation/short
cycle vs slow
inflation/long
cycle IPC.
Routine care of
hydrocolloid
dressings for
all, with no
other
compression.
Inpatient and
outpatient
setting.
104 1 h/d c
45 m
35 m
 an
Hg t
grou
inflat
inflat
susta
comp
12 s
Slow
60 s
30 s
comp
90 s
d, Day; h/d, hours/day; h, hour; IPC, intermittent pneumatic compression
ulcer.outcomes. PIn a well-designed study, IPCwas applied over 30 to 40
m Hg elastic compression stockings in patients with
enous ulcers.46 Patients were randomly assigned to one of
wo groups: compression stockings and routine wound care
N  24) or compression stockings, routine wound care,
nd adjunctive home-based IPC for 3 months or until ulcer
ealing (N  21). IPC was used 3 to 4 hours per day. By
eek 12, 48% of the IPC group had complete ulcer healing
s 11% in the stocking alone group (P .009). The median
lcer healing rate for the IPC group was 19.8% area per
eek vs 2.1% in the control group (P  .046).
Using patients as their own control, Mulder et al47
tudied the effect of a sequential compression device on 10
atients with chronic venous ulcers who failed to improve
fter 42 days of therapy with anUnna boot and elastic wrap.
ocol Duration Results Comments
gle-
PC at
g
min
s of
0 s of
on, and
flation.
3 mo Time to heal:
20 d – IPC
90 d – control
Return to
activity:
7 days – IPC
25 days –
control
Study not
randomized;
initial ulcer size
not documented;
no statistical
analysis
performed.
1 hr/day IPC
seems minimal
ression:
g ankle,
g calf
0 mm
in both
apid
.5 s
s
on,
ion.
ion:
ion,
ned
on,
ion.
6 mo or until
complete
ulcer
healing.
Ulcer healing:
45/52 – rapid
IPC
32/52 – slow
IPC (P 
.004)
Healing rate:
0.09 cm2 –
rapid IPC
0.04 cm2 –
slow IPC
(P  .0002).
First study
comparing 2
different IPC
compression
cycles. Only
patients with
pure venous
ulcers were
enrolled.
, intent-to-treat; IV, intravenous; mo, month; s, seconds; VLU, venous legprot
f sin
ber I
m H
ure. 1
s: 20
ion, 2
ined
ressi
of de
omp
m H
m H
kle; 3
high
ps. R
ion: 0
ion, 6
ined
ressi
deflat
inflat
inflat
sustai
ressi
deflat
; ITTatients were instructed to use the IPC device for 1 hour in
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Volume 53, Number 4 Comerota 1127the morning and 2 hours each evening, targeting healing at
120 days of treatment. Although only 1 patient healed by
the 120-day time point, all showed marked improvement.
Continued treatment resulted in complete healing of all but
1 patient.
In a study conducted by Schuler et al,48 53 patients
with chronic venous ulcers were randomly assigned to
receive either an Unna boot or sequential IPC with an
elastic stocking delivering 30 mm Hg compression at the
ankle. The stocking was worn all day, except during appli-
cation of the device. Follow-up was conducted once weekly
for 6months or until ulcer healing was complete. Complete
ulcer healing was achieved in 15 of 25 patients (60%) in the
Unna boot group, and in 20 of 28 patients (71%) in the
IPC group. Although the difference between groups was
not significant, the authors suggested that the combined
use of IPC and elastic compression stockings might be
preferable to the use of the Unna boot. Recognizing that a
30 mm Hg stocking does not apply enough pressure in
patients with C-6 disease, and that Unna boot-type gar-
ments are inelastic andmore effective than elastic garments,
this study probably underestimates the benefit of IPC in
patients with VLUs. Furthermore, the adjunctive use of
IPC is likely to be more effective when applied over the
compression garment (stocking) because compression is
additive.
In another study, 235 patients with venous ulcers re-
ceived either IPC using a compressor with full-leg cuffs plus
“classical” therapy (eg, elastic stockings, anticoagulants,
anti-infective dressings, antibiotics) or classical therapy
alone.49 Patients with IPC received 1 hour of IPC therapy
per day in addition to routine care. Ulcers healed faster in
the IPC group (mean, 20 days) than in the classical therapy
group (mean, 3 months). IPC shortened the duration of
treatment and facilitated return to an active life when
compared to routine care with compression stockings, thus
providing support for a wider application of IPC.However,
such observations might also reflect the inadequate com-
pression delivered by the stockings.
Nikolovska et al50 conducted the first study comparing
two different IPC regimens on ulcer healing, specifically
evaluating the speed of inflation and cycle times. They
randomized 104 patients with venous ulcers to rapid or
slow-compression IPC devices used for 1 hour daily. Both
devices applied the same pressure. No other compression
treatment was applied during the study period. The primary
endpoint of the study was the incidence of complete ulcer
healing by 6 months. The rapid-compression pump oper-
ated at three cycles/minute, whereas the slow compression
pump operated at one cycle every 3 minutes. Healing
occurred more often in patients treated with rapid IPC
(86% vs 61%; P  .004) and occurred sooner (P  .001).
This was the first study to demonstrate the clinical benefit
of rapid intermittent compression (three cycles/minute)
compared to slow intermittent compression, supporting
the concept that rapid cuff inflation with cycle times con-
sistent with venous filling times produces better clinical
results. Rapid inflation produces higher velocities and shear rtress on the vein wall and produces higher arterial-venous
radient. High-shear stress stimulates the endothelium to
elease nitric oxide,51,52 which in turn inhibits platelet
ggregation and platelet and monocyte adhesion. This
ndicates that the shear stress produced by IPC induces
hanges in endothelial cell function producing adaptation
f blood vessels, resulting in clinical effects that can be
easured, including improved arterial perfusion.
ISCUSSION
It is apparent that compression heals venous ulcers and
oo few patients are treated with proper compression. Ar-
itrary treatment duration of 12 or 16 weeks may not be
ong enough to heal large and chronic venous ulcers;
owever, with continued compression, success can be
chieved. Because VLUs are the sequelae of CVD, patients
ith healed VLUs remain at risk for ulcer recurrence if the
nderlying pathophysiology of their condition persists.
his observation is borne out by the results of the VenUS I
rial, in which 13% of ulcers that had initially healed in
atients treated with four-component bandages, and 25%
f ulcers treated with short-stretch bandages recurred after
2 months.11 This is likely the result of too little attention
o daily sustained compression. Although bandaging pro-
ides effective compression, IPC actively stimulates venous
eturn while favorably affecting a number of other physio-
ogic processes.
The effects of IPC observed in patients with venous
lceration alter the underlying pathophysiology, producing
n environment compatible with ulcer healing. Effects such
s increased venous return, reduced leg edema, increased
ndogenous fibrinolysis, reduced intravascular coagulation,
nd improved arterial (skin) perfusion resulting in increased
cPO2 combine to alter the wound environment in favor of
ealing. Therefore, it should not be surprising that well-
esigned clinical studies evaluating IPC added to standard
ound care and compression therapy show improved rates
f ulcer healing. The observations from these studies led to
he suggestions from the American College of Chest Phy-
icians that IPC be used to speed healing large VLUs and
hose recalcitrant to healing for 6 months.53
Table II summarizes clinical studies demonstrating im-
rovement in ulcer healing when IPC was added to routine
are. Although some reports are inconclusive, a review of
heir methods reveals a disparity in IPC protocols, pres-
ures, and cycle times, making it difficult to compare one
reatment regimen with another. Most of these studies
ere reported before guidelines for reporting the outcome
f venous ulcer treatment were published, emphasizing the
mportance of complete ulcer healing in preference to
ealing rate or percent healing. Clearly, there is a need for
dditional, well-designed clinical trials, which evaluates
PC as adjunctive treatment to standard care, which in-
ludes sustained compression.
Data suggest that the use of IPC as an adjunct to
ustained compression may be the optimal choice for treat-
ng patients with VLUs. However, a number of questions
emain with regard to its optimal use. For example, it is not
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compression. However, it seems clear that rapid inflation is
superior to slow inflation and that IPC which cycles at two
to three times per minute is superior to long cycle times
(one cycle per 2-3 minutes). Application of the device for 3
to 4 hours per day seems superior, although a critical study
on application times has not been performed. It seems
intuitive that the longer the application time per day, the
better the outcome should be.
Although healing of the ulcer is an important endpoint,
preventing recurrence, or, ideally, preventing the ulcer
from occurring in the first place, should be viewed as
optimal treatment. Proper (sustained) compression is im-
portant for the healing of ulcers and preventing their recur-
rence. Although compliance with IPC protocols has not
been an endpoint in previous studies, data suggest that
patients may prefer IPC to sustained, graduated compres-
sion.54 Ultimately, healing and preventing ulcer recurrence
will improve if compliance with compression therapy is
enhanced. The adjunctive use of IPC on the prevention of
recurrence has not been studied.
In conclusion, an overview of the literature suggests
that IPC speeds healing and increases the number of VLUs
healed by providing an environment favorable to wound
healing. Improved hematologic and hemodynamic effects
and reduced edema are likely major contributors. Well-
designed clinical studies in which IPC has been used have
demonstrated improved healing. Wider application of IPC
in patients with VLUs and further investigation in rigor-
ously controlled studies are warranted.
The author expresses appreciation to Jo AnnMayer and
Marilyn Gravett for their assistance with the preparation of
this article.
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